Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Maker Yielding Patent in Africa for AIDS Drug

March 15, 2001

Bristol-Myers Squibb has decided to give other companies the right to produce generic formulations of its stavudine AIDS drug for the African market. The company is also bringing the price of stavudine and didanosine to a combined $1 dollar per day for African nations. Executive vice president John L. McGoldrick asserts that his company is more interested in helping manage the continent's devastating epidemic than in making profits. ACT-UP Philadelphia's Kate Krauss states that the Bristol-Myers Squibb initiative is unprecedented in that the company admits that generic drugs are integral in saving lives, but activists remain disappointed that the company has not removed itself from the lawsuit against the South African government.


Other CDC News for March 15, 2001

Effectiveness of the Direct Observation Component of DOTS for Tuberculosis: a Randomized Controlled Trial in Pakistan

Maker Yielding Patent in Africa for AIDS Drug

Antiviral Cocktails Cut Cost of Treating Patients With HIV

Advertisement
South Africa Resists Call for AIDS Emergency
As AIDS Grows For Minorities, So Does Funding; Groups Assisting City's Blacks, Latinos Win Increased Support

The Danger of Living "Down Low"; Black Men Who Hide Their Bisexuality Can Put Women at Risk

A New AIDS Strategy

Brazil to Launch AIDS Vaccine Human Trials in April
Mogae Warns Botswana Faces Extinction From AIDS


Adapted from:
New York Times (www.nytimes.com)
03/15/01; P. A1; Petersen, Melody; McNeil Jr., Donald G.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 

 

Advertisement